{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:18:16Z","timestamp":1783070296280,"version":"3.54.6"},"reference-count":4,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>In their recent paper comparing three complexing protein-free botulinum toxin A products available on the market [...]<\/jats:p>","DOI":"10.3390\/toxins18070290","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:59:47Z","timestamp":1783065587000},"page":"290","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. Toxins 2026, 18, 142"],"prefix":"10.3390","volume":"18","author":[{"given":"Ulf","family":"St\u00e5hl","sequence":"first","affiliation":[{"name":"Galderma, Seminariegatan 21, 752 28 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Hamnevik","sequence":"additional","affiliation":[{"name":"Galderma, Seminariegatan 21, 752 28 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Liljegren Sundberg","sequence":"additional","affiliation":[{"name":"Galderma, Seminariegatan 21, 752 28 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Persson","sequence":"additional","affiliation":[{"name":"Galderma, Seminariegatan 21, 752 28 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Prygova","sequence":"additional","affiliation":[{"name":"Galderma, Seminariegatan 21, 752 28 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Honndorf, S., K\u00fchbach, K., Eisele, K.-H., Shokurova, A., Buch, P., Jatzke, C., Taylor, H.V., and Fink, K. (2026). Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. Toxins, 18.","DOI":"10.3390\/toxins18030142"},{"key":"ref_2","first-page":"1052","article-title":"IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines","volume":"20","author":"Kerscher","year":"2021","journal-title":"J. Drugs Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/asj\/sjae131","article-title":"Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results from the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar Lines","volume":"44","author":"Shridharani","year":"2024","journal-title":"Aesthet. Surg. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"St\u00e5hl, U., Lekholm, E., Hamnevik, E., Fredriksson, R., Shridharani, S.M., Taghetchian, K., Cohen, J.L., Nestor, M.S., and Sundberg, \u00c5.L. (2025). RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL Technology to Maintain High Biological and Specific Activity. Toxins, 17.","DOI":"10.3390\/toxins17100501"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/290\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:42:48Z","timestamp":1783068168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/7\/290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":4,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["toxins18070290"],"URL":"https:\/\/doi.org\/10.3390\/toxins18070290","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}